Ftse Mib
34.226,98
0,71%
DAX
18.330,52
0,87%
S&P 500
5.180,74
0,00%
NASDAQ
16.349,25
0,00%
Bitcoin
63.715,96
0,87%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Europa EU Oxurion NV (OXUR) Oxurion NV (OXUR) Notizie

OXUR

Oxurion NV (OXUR)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:EU:OXUR
DataOraFonteTitoloSimboloCompagnia
06/05/202418:00GlobeNewswire Inc.Important Advances in Oxurion's R&D Program on Geographic Atrophy secondary to AMDEU:OXUROxurion NV
25/04/202419:00GlobeNewswire Inc.Oxurion Receives Transparency Notification from Atlas Special Opportunities LLCEU:OXUROxurion NV
15/04/202417:16GlobeNewswire Inc.Publication Annual Report – Annual Shareholders' MeetingEU:OXUROxurion NV
11/04/202419:00GlobeNewswire Inc.Oxurion Receives Transparency Notifications from Atlas Special Opportunities LLCEU:OXUROxurion NV
10/04/202419:00GlobeNewswire Inc.Oxurion Receives EUR 450,000 in the framework of the Atlas Funding Program : Eleventh tranche fully issued and paid-upEU:OXUROxurion NV
05/04/202414:00GlobeNewswire Inc.Postponement Annual Shareholders Meeting - Amendment financial calendarEU:OXUROxurion NV
27/03/202419:00GlobeNewswire Inc.Information on the Total Number of Voting Rights (Denominator) following Conversion Notices from Atlas - Amended versionEU:OXUROxurion NV
26/03/202419:00GlobeNewswire Inc.Information on the Total Number of Voting Rights (Denominator) following Conversion Notices from AtlasEU:OXUROxurion NV
25/03/202419:10GlobeNewswire Inc.OXURION announces its presence at the Paris SmallCap event on March 28, 2024.EU:OXUROxurion NV
05/03/202419:00GlobeNewswire Inc.Oxurion Receives EUR 300,000 in the framework of the Atlas Funding Program Tenth tranche fully issued and paid-upEU:OXUROxurion NV
22/01/202422:02GlobeNewswire Inc.Oxurion Announces New Strategic Orientation to De-risk and DiversifyEU:OXUROxurion NV
28/12/202321:15GlobeNewswire Inc.Oxurion Avoids Bankruptcy, Announces Board and Management Changes and Enters into Binding Letter of Intent with its Main Creditor AtlasEU:OXUROxurion NV
20/11/202307:00GlobeNewswire Inc.Oxurion Discloses Topline Data from KALAHARI Phase 2, Part B Trial of Novel PKal Inhibitor THR-149 in Diabetic Macular EdemaEU:OXUROxurion NV
19/11/202321:00GlobeNewswire Inc.Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from AtlasEU:OXUROxurion NV
16/11/202319:00GlobeNewswire Inc.Oxurion Receives EUR 1.0 Million under Amended Atlas Funding Program   Total of EUR 3.5 Million in Unconditional Funding Allowing Company to Reach Topline Data from KALAHARI Trial This YearEU:OXUROxurion NV
25/10/202308:00GlobeNewswire Inc.Oxurion Receives EUR 1.5 Million under Amended Atlas Funding Program; Total of EUR 3.5 Million in Unconditional Funding Allowing Company to Achieve Topline Data from KALAHARI TrialEU:OXUROxurion NV
29/09/202319:00GlobeNewswire Inc.Oxurion Publishes First Half 2023 ResultsEU:OXUROxurion NV
18/09/202308:04GlobeNewswire Inc.Oxurion Receives First EUR 1 Million under Amended Atlas Funding ProgramEU:OXUROxurion NV
11/09/202308:00GlobeNewswire Inc.Oxurion Announces Key Amendments to Atlas and Kreos/Pontifax Agreements Enabling KALAHARI Trial to Progress to Topline Results in 2023EU:OXUROxurion NV
11/08/202308:08GlobeNewswire Inc.Oxurion Receives Funding of EUR One Million under Atlas Special Opportunities LLC (Atlas) Funding ProgramEU:OXUROxurion NV
26/07/202319:00GlobeNewswire Inc.Oxurion Receives Transparency Notifications from Atlas Special Opportunities LLEU:OXUROxurion NV
25/07/202308:00GlobeNewswire Inc.Oxurion Receives Upfront Payment of $400,000 Following Oncurious Asset License by VIB  EU:OXUROxurion NV
14/07/202319:00GlobeNewswire Inc.Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC  EU:OXUROxurion NV
15/06/202319:02GlobeNewswire Inc.Oxurion Issues EUR 1.0 million in Bonds for Tranche 3 of the Funding Program with Atlas Special Opportunities LLCEU:OXUROxurion NV
12/06/202320:00GlobeNewswire Inc.Oxurion Receives Transparency Notifications from Atlas Special Opportunities LLC  EU:OXUROxurion NV
12/06/202308:00GlobeNewswire Inc.Oxurion Finalizes Enrollment in KALAHARI Phase 2, Part B Trial of Novel PKal Inhibitor THR-149 in Diabetic Macular EdemaEU:OXUROxurion NV
09/06/202308:00GlobeNewswire Inc.Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from ATLASEU:OXUROxurion NV
05/06/202319:00GlobeNewswire Inc.Oxurion Announces Results of the Extraordinary Shareholders’ Meeting of 22 May 2023EU:OXUROxurion NV
01/06/202308:00GlobeNewswire Inc.Oxurion to Participate in Upcoming ConferencesEU:OXUROxurion NV
25/05/202321:00GlobeNewswire Inc.Oxurion Reaches Enrollment Target in KALAHARI Phase 2, Part B Trial of Novel PKal Inhibitor THR-149 in Diabetic Macular EdemaEU:OXUROxurion NV
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:EU:OXUR

La tua Cronologia

BIT
UCG
Unicredit
BIT
RACE
Ferrari NV
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
CPR
Davide Campari
BIT
ISP
Intesa Sanpaolo
BIT
STMMI
ST Microelectronics
BIT
STLAM
Stellantis NV
BIT
ENEL
Enel
BIT
FBK
Finecobank
BIT
ENI
Eni
BIT
IRE
Iren
BIT
TEN
Tenaris
BIT
LDO
Leonardo
BIT
SRG
Snam
BIT
BPE
Bper Banca
BIT
BAMI
Banco BPM
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network